This Horizon Europe call aims to advance bio-printing technologies using living cells for regenerative medicine. Projects should develop and demonstrate advanced bio-printing solutions capable of producing functional human tissues, with the longer-term goal of enabling safer and more effective advanced therapies for patients with unmet medical needs.

The call seeks to bring together biomedical research and technological expertise to develop integrated bio-printing systems and provide healthcare professionals with the knowledge and tools needed for their safe and effective use. Particular emphasis is placed on supporting personalised regenerative medicine and translating innovative bio-printing technologies towards future clinical applications.

The topic is particularly relevant for universities and research organisations, biomedical scientists, technology developers, healthcare providers and industry partners working in regenerative medicine, tissue engineering, bio-printing and advanced therapies.

The call is expected to fund approximately four projects, with an indicative EU contribution of EUR 7-10 million per project.